Fostering a healthy quality culture

Published: 1-Oct-2021
Regulatory

In the pharma industry, many use regulatory inspection history and audit reports to get a feel for how a manufacturing operation is run from a compliance/quality standpoint. But TriRx believes these are just one of the many ways to gauge quality history, systems, and culture at an organisation

In the latest article below, TriRx’s co-founder, Director, Executive Vice President, and Chief Operations Officer Jim Scandura and Executive Vice President, Quality Chief, and Chief Quality and Regulatory Affairs Officer Don Britt discuss the importance of quality systems at CDMOs and possible red flags of a suffering quality culture.

At TriRx, quality culture is a fundamental part of the company, not just a buzzword. Learn more about the importance and evolution of quality systems and quality culture.

  • Companies:
  • TriRx Pharmaceutical Services
See more

You may also like

Manufacturing

IMed Consultancy helps Toby Orthopaedics navigate UK regulations

Read more
Regulatory consultancy ensures compliance and confidence for Miami-based company

Trending Articles

  1. IMed Consultancy helps Toby Orthopaedics navigate UK regulations Regulatory consultancy ensures compliance and confidence for Miami-based company
  2. IMed supports K2 medical systems in their EU MDR transition Consultancy firm helps K2 navigate the complex regulatory process to achieve Article 97 compliance
  3. Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
  4. Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
  5. Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format

Upcoming event

CPhI India

26–28 November 2024 | Online Conference & Networking | Delhi, India See all

You may also like

Manufacturing

IMed Consultancy helps Toby Orthopaedics navigate UK regulations

Regulatory consultancy ensures compliance and confidence for Miami-based company
Manufacturing

Ardena's Oss nanomedicine facility gains full GMP approval from the Dutch Healthcare Authority

The pharmaceutical manufacturing facility can produce advanced nanoparticle drug delivery systems, including lipid-based, polymeric and metal oxide nanoparticles
Regulatory

Pfizer gains European Commission approval for haemophilia A and B drug, Hympavzi

The subcutaneous therapeutic is the first and only anti-tissue factor pathway inhibitor approved for the treatment of haemophilia A or B, and is available in an auto-injector format
Regulatory

Syndax Pharmaceuticals' leukaemia drug Revuforj bags FDA approval

The therapeutic is the first and only menin inhibitor to gain FDA approval for acute relapsed or refractory acute leukaemia
Design & Build

Cleancube multi: Guardtech’s container facilities support NHS aseptic pharmacies

Award-winning mobile cleanrooms offer fast, flexible solutions for facility upgrades
Regulatory

AbbVie's Elahere approved for platinum-resistant ovarian cancer by the European Commission

Elahere is the first FRα-targeting antibody-drug conjugate (ADC) to be approved in Europe for platinum-resistant ovarian cancer
Regulatory

PTC Therapeutics' gene therapy Kebilidi bags FDA approval for AADC deficiency

The gene therapy is the first to be approved in the US for direct administration to the brain, and tackles aromatic L-amino acid decarboxylase deficiency (AADC)
Subscribe now